Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Validation Study

Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Validation Study

Quick Info:

Status:
Currently Recruiting
Estimated Enrollment:
50
Phase:
n/a
Treatment Type:
Diagnostic Test: ECAS-N & Diagnostic Test: MoCA
Trial Type:
Cohort enrollment, prospective
Sponsor:
Haukeland University Hospital
Primary Investigator:
Contact Information:

Trial Goal:

Care and Management

Care and Management

Emerging strategies to improve QoL of PALS
Tests to Expect:
Cognitive Tests

Cognitive Tests

Update Notes:

7/9/2018Trial added

Locations:

Haukeland University Hospital , Bergen, 5021

Other Information:

Purpose: Cognitive impairment is present in about 30-50% of the patients with amyotrophic lateral sclerosis (ALS). Suitable screening tools are available, but none of these are evaluated in a Norwegian population.
Eligibility: 35 Years to 85 Years, all genders, accepting healthy volunteers
Details:
Collaborator(s):
News Articles and Summaries:
ALS Forum:
First Published on Clinicaltrials.gov: 7/9/2018
ClinicalTrials.gov ID: NCT03579017
Trial Protocol as Published on Clinicaltrials.gov:
ClinicalTrials.gov